In 1970, Richard Nixon signed into law the Poison Prevention Packaging Act (PPPA). The act was written in response to a growing number of child poisonings from unintentional ingestion of drugs and other products. The Act was successful, but a lot has changed in the last 47 years.
The recently introduced Bill HR 1245 IH, the ‘‘Affordable and Safe Prescription Drug Importation Act’’ attempts to open the door to lower cost drugs via Canadian pharmacies.
U.S. government-mandated serialization is creating a scramble in the pharmaceutical packaging world. Track and trace solutions must meet Drug Supply Chain Security Act (DSCSA) compliance by November of this year.
Healthcare is a booming business in the United States, and that fact is creating tremendous growth opportunities for both pharmaceutical and medical device packaging.
As fall 2016 kicks in, pharmaceutical manufacturers and those involved in the supply chain are grappling with the roll out of The Drug Supply Chain Security Act (DSCSA).
As the newest member of Pharma Tech’s leadership team, Kaneps’ primary role will be developing and maintaining new supply chain relationships with both current and potential customers.
Rising utilization of packaging materials that offers optimal protection and safety allowing to extend product shelf life is projected to boost market demand over the forecast period.